<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00253695</url>
  </required_header>
  <id_info>
    <org_study_id>1317</org_study_id>
    <secondary_id>R01HL079533</secondary_id>
    <nct_id>NCT00253695</nct_id>
  </id_info>
  <brief_title>Sleep, HIV Disease Progression, and Function in HIV Infected Children and Adolescents</brief_title>
  <official_title>Sleep Studies in HIV+ Older Children/Adolescents</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Baylor College of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Baylor College of Medicine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a first step in approaching the gap existing between understanding sleep
      abnormalities, alterations in sleep-regulating cytokines and HIV-1 disease regulating
      cytokines, and abnormal higher cortical function.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      BACKGROUND:

      In the growing number of HIV infected youth and young adults, it is important to study the
      effects of HAART treatment on sleep patterns and related neurocognitive and psychosocial
      function.

      DESIGN NARRATIVE (including primary and secondary outcomes):

      Using validated sleep questionnaires and actigraphy measurements, overnight polysomnography
      (PSG, sleep study) will assess the degree of abnormal sleeping patterns and daytime
      sleepiness in HIV infected children and HIV uninfected children (control group).

      The following peripheral blood levels will be measured over a 24-hour period, at multiple
      time points, in all participants: TNF-alphaRI and IL-6 (sleep-regulating cytokines);
      IFN-gamma and IL-12 (cytotoxic or TH1 cytokines); and IL-10 and IL-1RA (inflammatory or TH2
      cytokines). This will help to determine the association between alterations in
      sleep-regulating cytokines and HIV disease progression (CD4+ T-cell count, HIV-1 RNA level).

      Neurocognitive and neuropsychological tests will be performed on all participants to
      determine if there is an association between lack of normal sleeping habits, alterations in
      sleep-regulating cytokines and HIV-1 disease progression cytokines, and
      neurocognitive/neuropsychological performance.

      Computer analysis of electroencephalography (EEG) will be performed during wakefulness and
      all stages of sleep to determine if greater disease severity, sleepiness, sleep disruption,
      and neurocognitive impairment is associated with increased amounts of slow activity.
      Improvement in these related factors will be associated with normalizations of these
      parameters. For some of these quantitative measures, the findings may be more significant for
      particular brain regions; for example, frontal regions in the case of attention problems.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2004</start_date>
  <completion_date type="Actual">September 2009</completion_date>
  <primary_completion_date type="Actual">September 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Association of cytokines, sleep patterns, and neurocognitive function in youth with HIV.</measure>
    <time_frame>11/2005 - 02/2009</time_frame>
    <description>Observational study only</description>
  </primary_outcome>
  <enrollment type="Actual">90</enrollment>
  <condition>Sleep</condition>
  <condition>HIV Infections</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Wrist Actigraphy</intervention_name>
    <description>Wrist actigraph will record participants' sleeping patterns.</description>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        HIV-infected children with and without asthma.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        HIV Group

          -  HIV-1 infection

        Control Group

          -  Family members and friends of HIV-1 infected children

        Exclusion Criteria:

        HIV Group

          -  Pregnancy

        Control Group

          -  Pregnancy

          -  Asthma

          -  Sleep apnea
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>8 Years</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>William Shearer, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Texas Children's Hospital/Baylor College of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Texas Children's Hospital/Baylor College of Medicine</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Foster SB, Paul ME, Kozinetz CA, Macias CG, Shearer WT. Prevalence of asthma in children and young adults with HIV infection. J Allergy Clin Immunol. 2007 Mar;119(3):750-2.</citation>
    <PMID>17336620</PMID>
  </reference>
  <reference>
    <citation>Foster SB, Paul ME, Glaze DG, Reuben JM, Harris LL, Cohen EN, Lee B-N, Kozinetz CA, Schwarzwald HL, Kline MW, Jackson CD, Loeb AJ, Frerking PR, Brouwers PY, Shearer WT. Viremia is associated with sleep disturbances, neurocognitive disorders and cytokine dysregulation in pediatric HIV infection. J Allergy Clin Immunol 2007;119;S232.</citation>
  </reference>
  <reference>
    <citation>Alvarez JA, Scully RE, Miller TL, Armstrong FD, Constine LS, Friedman DL, Lipshultz SE. Long-term effects of treatments for childhood cancers. Curr Opin Pediatr. 2007 Feb;19(1):23-31. Review.</citation>
    <PMID>17224658</PMID>
  </reference>
  <reference>
    <citation>Armstrong FD. Neurodevelopment and chronic illness: Mechanisms of disease and treatment. Ment Retard Dev Disabil Res Rev. 2006;12(3):168-73. Review.</citation>
    <PMID>17061286</PMID>
  </reference>
  <reference>
    <citation>Fisher SD, Miller TL, Lipshultz SE. Impact of HIV and highly active antiretroviral therapy on leukocyte adhesion molecules, arterial inflammation, dyslipidemia, and atherosclerosis. Atherosclerosis. 2006 Mar;185(1):1-11. Epub 2005 Nov 16. Review.</citation>
    <PMID>16297390</PMID>
  </reference>
  <reference>
    <citation>Kozinetz CA, Matusa R, Hacker CS. Biologic and social determinants of sequelae and long-term survival of pediatric HIV in Romania. Ann Epidemiol. 2006 Aug;16(8):593-9. Epub 2006 Jan 23.</citation>
    <PMID>16431133</PMID>
  </reference>
  <reference>
    <citation>Lewis DE, Gross KL, Diez MM, Martinez ML, Lukefahr HN, Kozinetz CA, Arduino RC. CD8 apoptosis may be a predictor of T cell number normalization after immune reconstitution in HIV. J Transl Med. 2007 Jan 30;5:9.</citation>
    <PMID>17263884</PMID>
  </reference>
  <reference>
    <citation>Lipshultz SE, Fisher SD, Sharma T, Milton A, Miller TL. HIV-associated cardiovascular disease. Dialogues in Cardiology 2007, in press.</citation>
  </reference>
  <reference>
    <citation>Macias CG, Caviness AC, Sockrider M, Brooks E, Kronfol R, Bartholomew LK, Abramson S, Shearer W. The effect of acute and chronic asthma severity on pediatric emergency department utilization. Pediatrics. 2006 Apr;117(4 Pt 2):S86-95.</citation>
    <PMID>16777836</PMID>
  </reference>
  <reference>
    <citation>Mitchell CD, Armstrong FD, Goodman KW, Cava A. Disclosure of HIV status to an infected child: medical, psychological, ethical, and legal perspectives in an era of &quot;super-vertical&quot; transmission. J Clin Ethics. 2008 Spring;19(1):43-52.</citation>
    <PMID>18552052</PMID>
  </reference>
  <reference>
    <citation>Nathan PC, Patel SK, Dilley K, Goldsby R, Harvey J, Jacobsen C, Kadan-Lottick N, McKinley K, Millham AK, Moore I, Okcu MF, Woodman CL, Brouwers P, Armstrong FD; Children's Oncology Group Long-term Follow-up Guidelines Task Force on Neurocognitive/Behavioral Complications After Childhood Cancer. Guidelines for identification of, advocacy for, and intervention in neurocognitive problems in survivors of childhood cancer: a report from the Children's Oncology Group. Arch Pediatr Adolesc Med. 2007 Aug;161(8):798-806. Review.</citation>
    <PMID>17679663</PMID>
  </reference>
  <reference>
    <citation>Shearer WT, DeVille JG, Samson PM, Moye JH Jr, Fletcher CV, Church JA, Spiegel HM, Palumbo P, Fenton T, Smith ME, Graham B, Kraimer JM, Olson WC. Susceptibility of pediatric HIV-1 isolates to recombinant CD4-IgG2 (PRO 542) and humanized mAb to the chemokine receptor CCR5 (PRO 140). J Allergy Clin Immunol. 2006 Aug;118(2):518-21. Epub 2006 May 19.</citation>
    <PMID>16890780</PMID>
  </reference>
  <reference>
    <citation>Pacheco SE, McIntosh K, Lu M, Mofenson LM, Diaz C, Foca M, Frederick M, Handelsman E, Hayani K, Shearer WT; Women and Infants Transmission Study. Effect of perinatal antiretroviral drug exposure on hematologic values in HIV-uninfected children: An analysis of the women and infants transmission study. J Infect Dis. 2006 Oct 15;194(8):1089-97. Epub 2006 Sep 11.</citation>
    <PMID>16991083</PMID>
  </reference>
  <reference>
    <citation>Williamson MP, McCormick TG, Nance CL, Shearer WT. Epigallocatechin gallate, the main polyphenol in green tea, binds to the T-cell receptor, CD4: Potential for HIV-1 therapy. J Allergy Clin Immunol. 2006 Dec;118(6):1369-74. Epub 2006 Oct 13.</citation>
    <PMID>17157668</PMID>
  </reference>
  <reference>
    <citation>HIV Paediatric Prognostic Markers Collaborative Study. Predictive value of absolute CD4 cell count for disease progression in untreated HIV-1-infected children. AIDS. 2006 Jun 12;20(9):1289-94.</citation>
    <PMID>16816558</PMID>
  </reference>
  <reference>
    <citation>Fletcher CV, DeVille JG, Samson PM, Moye JH Jr, Church JA, Spiegel HM, Palumbo P, Fenton T, Smith ME, Graham B, Kraimer JM, Shearer WT; Pediatric AIDS Clinical Trials Group, Protocol 351 Study Group. Nonlinear pharmacokinetics of high-dose recombinant fusion protein CD4-IgG2 (PRO 542) observed in HIV-1-infected children. J Allergy Clin Immunol. 2007 Mar;119(3):747-50.</citation>
    <PMID>17336619</PMID>
  </reference>
  <results_reference>
    <citation>Foster SB, Lu M, Glaze DG, Reuben JM, Harris LL, Cohen EN, Lee BN, Zhao E, Paul ME, Schwarzwald H, McMullen-Jackson C, Clark C, Armstrong FD, Brouwers PY, Miller TL, Colin AA, Scott GB, Shahzeidi S, Willen EJ, Asthana D, Lipshultz SE, Thompson BW, Shearer WT. Associations of cytokines, sleep patterns, and neurocognitive function in youth with HIV infection. Clin Immunol. 2012 Jul;144(1):13-23. doi: 10.1016/j.clim.2012.04.004. Epub 2012 May 2.</citation>
    <PMID>22659030</PMID>
  </results_reference>
  <verification_date>March 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 10, 2005</study_first_submitted>
  <study_first_submitted_qc>November 10, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 15, 2005</study_first_posted>
  <last_update_submitted>March 26, 2013</last_update_submitted>
  <last_update_submitted_qc>March 26, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 28, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Baylor College of Medicine</investigator_affiliation>
    <investigator_full_name>William Shearer</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>HIV Infections</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

